A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Novo Nordisk board members step down after major shareholder dispute
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Planned 5-day strike at Kaiser Permanente facilities ends, further talks planned
SAN FRANCISCO — SAN FRANCISCO (AP) — A planned five-day strike by thousands of registered nurses and other…
These people will lose if Affordable Care Act health subsidies expire
TYLER, Texas (AP) — Celia Monreal worries every day about the cartilage loss in her husband’s knees. Not…
We’re downgrading it, considering next move
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue…
How Lego MRI scanner sets are reducing anxiety in children
People depart a Lego store in Manhattan on August 29, 2024 in New York City. Spencer Platt |…
Novo Nordisk to buy Akero Therapeutics
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case
In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
Health care is one of the most intractable issues in Congress
WASHINGTON — WASHINGTON (AP) — Democrats believe health care is an issue that resonates with a majority of…
Health care remains an intractable issue in Congress
WASHINGTON (AP) — Democrats believe health care is an issue that resonates with a majority of Americans as…
Pfizer’s new obesity bet, Metsera, releases drug data
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…
Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said…